It's happening anew.
At the beginning of last month, a group of unexplained child deaths in a rural community in Madhya Pradesh sent local health workers working urgently.
No fewer than 11 children - between one to six - had died shortly of taking a common cough syrup. Authorities tested sources ranging from tap water to insects until the truth emerged: their renal systems had stopped functioning.
Weeks later, a state laboratory in Chennai confirmed the worst. The medicine under scrutiny contained nearly half toxic solvent, a poisonous chemical that should never be present in medication. Renal shutdown is frequent after consuming this poisonous alcohol.
Broadening Crisis
The horror extended beyond to the initial location. In adjacent Rajasthan, the fatalities of a pair of young children, reportedly after taking a regionally produced Dextromethorphan syrup - medication unsafe for very young children - sparked public anger and a government investigation.
For India, this caused a disturbing sense of déjà vu.
Over the years, diethylene glycol in domestically produced cold medicines has claimed many of young lives. In 2023, Indian syrups contaminated with diethylene glycol were connected to the deaths of 70 children in Africa and 18 in Central Asia.
From late 2019 and January 2020, no fewer than 12 kids under five died in northern India allegedly from cough syrup, with advocates suggesting the number of casualties might have been greater. In the past, there's also been misuse of cough syrups containing codeine, a substance that can produce euphoria in large quantities and cause addiction, and is discouraged for young children.
Regulatory Shortcomings
Each time regulators vow reform, tainted syrups reappear - demonstrating a fragmented drug market and, critics allege, a ineffective oversight mechanism struggling to monitor numerous of cheap, often unauthorized syrups produced by smaller manufacturers and available without prescription.
Shortly after the most recent fatalities, India's medical authorities urged rational use of such medicines - essentially cautioning physicians to practice more care when recommending them to young children - confiscated samples of the medicine, halted and prohibited distribution, and initiated an investigation.
Market Growth and Healthcare Reality
However the issue, experts argue, is more fundamental than over-prescription. Every fresh tragedy exposes the flaws in the country's drug oversight system - a complex network of poor implementation and control. The Indian cough syrup market is set to soar from over two hundred million dollars in 2024 to $743m by 2035, expanding at a compound annual rate of 9.9%, as per market research.
Yet these incidents would happen if the nation, and its citizens, could reduce their reliance with cough syrups. For many years, physicians have prescribed them, and patients have used them, even though most do little good and can possibly cause significant damage.
Advertised as quick relief for throat pain and stubborn coughs, these flavored medicines combine sugar, dyes and flavorings with a combination of allergy medications, decongestants, mucus thinners.
Clinical Perspective
Theoretically, every component has a function: one dries secretions, others loosens phlegm, a third suppresses the coughing impulse. Realistically, research of them being effective is small - the majority of respiratory issues get better on their own in a few days.
A respiratory symptom can be caused by either infection or an allergic reaction. Cold medications generally fall into two categories - calming agents that enable the youngster sleep, and airway openers that improve respiration - and physicians usually prescribe one or the other, not a combination.
The majority of persistent respiratory issues in kids in heavily contaminated Indian cities are unrelated to illness but by immune reactions and irritation of the lower airways, according to children's doctors. Hypersensitivity reactions happen when the body's defenses overreacts to stimuli such as particles and contaminants.
These children frequently have a cold and a respiratory issue that worsens at night or dawn, repeating every few weeks. In urban centers, these recurrent, wet symptoms are typically triggered by dust and air pollution, sometimes accompanied by mild airway constriction.
Management Approaches
Doctors said such coughs respond best to bronchodilators - medicines that open up the airways - preferably through puffers or nebulisers, though many physicians continue using syrups that offer only limited relief.
The majority of childhood respiratory issues are virus-caused, self-limiting, and resolve on their own within a few days. Medical experts say no syrup reduces their course; at most, they offer temporary relief. At their most dangerous, they pose risks of addiction, poisoning and overdose.
"I typically avoid recommend cough syrups for common coughs and respiratory infections - other than sometimes for symptom relief. If a youngster is severely symptomatic and has difficulty resting, I may give a small amount of a mild syrup just to ease the discomfort. The main goal is comfort, not cure, especially when the cough is non-productive and associated with a common illness," explains a children's doctor.
Root Causes
What explains is medication so widely prescribed in India?
One reason is the deficiency of the nation's basic medical infrastructure, especially in rural communities and rural areas. As rising air pollution fuels chronic coughs, they are progressively misused for routine respiratory infections.
This issue runs deeper in the countryside. In villages, up to three-quarters of basic medical consultations are managed by unqualified practitioners - frequently untrained rural medical practitioners without proper education.
In locations where the local public health clinic is distant, under-staffed, or closed, they are the de facto doctors - and medications are their most trusted treatments. When posted in Gorakhapur, a
